Metagenomi Therapeutics, Inc. (MGX)

SEC filing

Metagenomi Therapeutics, Inc.

MGX · CIK 1785279

4 · Dec 1, 2025 · Wein Matthew sold 199 shares at $1.81/share ($360); was granted 96K shares at $1.60/share ($153.6K)

Wein Matthew sold 199 shares at $1.81/share ($360); was granted 96K shares at $1.60/share ($153.6K)

xslF345X05/ownership.xml

xslF345X05/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).